help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on December 6, 2007
Endocrinology, doi:10.1210/en.2007-1350
A more recent version of this article appeared on March 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
149/3/869    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vulliemoz, N. R
Right arrow Articles by Ferin, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vulliemoz, N. R
Right arrow Articles by Ferin, M.

Submitted on October 1, 2007
Accepted on November 28, 2007

Astressin B, a non selective CRH receptor antagonist, prevents the inhibitory effect of Ghrelin on LH pulse frequency in the ovariectomized rhesus monkey

Nicolas R Vulliemoz, Ennian Xiao, Linna Xia-Zhang, Jean Rivier, and Michel Ferin*

Departments of Obstetrics and Gynecology of the College of Physicians and Surgeons, Columbia University, New York, NY 10032 (EX, LXZ, MF), and of the Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland (NRV); and The Salk Institute, La Jolla, CA 92307 (JR)

* To whom correspondence should be addressed. E-mail: mf8{at}columbia.edu.

Administration of ghrelin, a key peptide in the regulation of energy homeostasis, has been shown to decrease LH pulse frequency while concomitantly elevating cortisol levels. Because increased endogenous CRH release in stress is associated with an inhibition of reproductive function, we have tested here whether pulsatile LH decrease following ghrelin may reflect an activated HPA axis and be prevented by a CRH antagonist. After a 3h baseline LH pulse frequency monitoring, 5 adult OVX rhesus monkeys received a 5h- saline (protocol 1) or ghrelin infusion (100µg bolus followed by 100µg/h, protocol 2). In protocols 3 and 4, animals were given astressin B, a non specific CRH receptor antagonist (0.45mg/kg im), 90 min prior to ghrelin or saline infusion. Blood samples were taken every 15 min for LH measurements, while cortisol and GH were measured every 45 min. Mean LH pulse frequency during the 5h ghrelin infusion was significantly lower than in all other treatments (p<0.05) and when compared to the baseline period (p<0.05). Pretreatment with astressin B prevented the decrease. Ghrelin stimulated cortisol and GH secretion, while astressin B pretreatment prevented the cortisol, but not the GH, release. Our data indicate that CRH release mediates the inhibitory effect of ghrelin on LH pulse frequency and suggest that the inhibitory impact of an insufficient energy balance on reproductive function may in part be mediated by the HPA axis.


Key words: CRH receptor antagonist • ghrelin • LH pulse frequency • monkey







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society